Editorial from the HIV/AIDS Section’s Chief:

May 15, 2014: Further Evidence of a “Functional Cure” of HIV Infected Infants

In March 2013, researchers reported on the case of the “Mississippi Baby [1].” The baby girl  born to an HIV-infected mother who was diagnosed during labour having had no prenatal care.  The mother therefore had not received antiretroviral medicines to protect her health or prevent HIV transmission to her baby during pregnancy.  The standard protocol for all infants born to HIV-infected mothers, as recommended by WHO, is to provide the baby with the antiretroviral drug nevirapine or zidovudine, used as prophylaxis, or to prevent, HIV acquisition.  In the case of the Mississippi Baby, the doctor, knowing there was a high risk the baby was infected …
Read More